Involvement of the cannabinoid CB2 receptor and its endogenous ligand 2-arachidonoylglycerol in oxazolone-induced contact dermatitis in mice

Journal of Immunology

Volumn 177, Issue 12, 2006, Pages 8796-8805

  Oka, Saori ^a   Wakui, Junichi ^a   Ikeda, Shinobu ^a   Yanagimoto, Shin ^a   Kishimoto, Seishi ^a   Gokoh, Maiko ^a   Nasui, Miwako ^a   Sugiura, Takayuki ^a  

^a TEIKYO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 2 ARACHIDONOYLGLYCEROL; 5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; HYDROCORTISONE ACETATE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA; OXAZOLONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTACT DERMATITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; EAR; EOSINOPHIL; KERATINOCYTE; LANGERHANS CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROVOCATION TEST; SENSITIZATION;

EID: 33845383265     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.12.8796     Document Type: Article

References (52)

1. 2 receptors. Pharmacol. Ther. 74: 129-180.
2. Matsuda, L. A., S. J. Lolait, M. J. Brownstein, A. C. Young, and T. I. Bonner. 1990. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346: 561-564.
3. Herkenham, M. 1995. Localization of cannabinoid receptors in brain and periphery. In Cannabinoid Receptors. R. G. Pertwee, ed. Academic Press, London, pp. 145-166.
4. Di Marzo, V., D. Melck, T. Bisogno, and L. De Petrocellis. 1999. Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action. [Published erratum appears in Trends Neurosci. 22: 80.] Trends Neurosci. 21: 521-528.
5. Munro, S., K. L. Thomas, and M. Abu-Shaar. 1993. Molecular characterization of a peripheral receptor for cannabinoids. Nature 365: 61-65.
6. Klein, T. W., C. Newton, and H. Friedman. 1998. Cannabinoid receptors and immunity. Immunol. Today 19: 373-381.
7. Parolaro, D., P. Massi, T. Rubino, and E. Monti. 2002. Endocannabinoids in the immune system and cancer. Prostaglandins Leukotrienes Essent. Fatty Acids 66: 319-332.
8. Cabral, G. A. 2002. Marijuana and cannabinoid effects in immunity and AIDS. In Biology of Marijuana. E. S. Onaivi, ed. Tayler & Francis, London, pp. 282-307.
9. Klein, T. W., C. Newton, K. Larsen, L. Lu, I. Perkins, L. Nong, and H. Friedman. 2003. The cannabinoid system and immune modulation. J. Leukocyte Biol. 74: 486-496.
10. Berdyshev, E. V. 2006. Endocannabinoids in inflammation and immune response. In Endocannabinoids: The Brain and Body's Marijuana and Beyond. E. S. Onaivi, T. Sugiura, and V. Di Marzo, eds. Taylor & Francis, Boca Raton, pp. 431-450.
11. Devane, W. A., L. Hanus, A. Breuer, R. G. Pertwee, L. A. Stevenson, G. Griffin, D. Gibson, A. Mandelbaum, A. Etinger, and R. Mechoulam. 1992. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258: 1946-1949.
12. Sugiura, T., S. Kondo, A. Sukagawa, S. Nakane, A. Shinoda, K. Itoh, A. Yamashita, and K. Waku. 1995. 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem. Biophys. Res. Commun. 215: 89-97.
13. Mechoulam, R., S. Ben-Shabat, L. Hanus, M. Ligumsky, N. E. Kaminski, A. R. Schatz, A. Gopher, S. Almog, B. R. Martin, D. R. Compton, et al. 1995. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem. Pharmacol. 50: 83-90.
14. Sugiura, T., and K. Waku. 2000. 2-Arachidonoylglycerol and the cannabinoid receptors. Chem. Phys. Lipids 108: 89-106.
15. Sugiura, T., Y. Kobayashi, S. Oka, and K. Waku. 2002. Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance. Prostaglandins Leukotrienes Essent. Fatty Acids 66: 173-192.
16. Stella, N., P. Schweitzer, and D. Piomelli. 1997. A second endogenous cannabinoid that modulates long-term potentiation. Nature 388: 773-778.
17. Varga, K., J. A. Wagner, D. T. Bridgen, and G. Kunos. 1998. Platelet- and macrophage-derived endogenous cannabinoids are involved in endotoxin-induced hypotension. FASEB J. 12: 1035-1044.
18. Di Marzo, V., T. Bisogno, L. De Petrocellis, D. Melck, P. Orlando, J. A. Wagner, and G. Kunos. 1999. Biosynthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in circulating and tumoral macrophages. Eur. J. Biochem. 264: 258-267.
19. Berdyshev, E. V., P. C. Schmid, R. J. Krebsbach, and H. H. O. Schmid. 2001. Activation of PAF receptors results in enhanced synthesis of 2-arachidonoylglycerol (2-AG) in immune cells. FASEB J. 15: 2171-2178.
20. Sugiura, T., T. Kodaka, S. Nakane, T. Miyashita, S. Kondo, Y. Suhara, H. Takayama, K. Waku, C. Seki, N. Baba, and Y. Ishima. 1999. Evidence that the cannabinoid CB1 receptor is a 2-arachidonoylglycerol receptor: structure-activity relationship of 2-arachidonoylglycerol, ether-linked analogues, and related compounds. J. Biol. Chem. 274: 2794-2801.
21. Sugiura, T., S. Kondo, S. Kishimoto, T. Miyashita, S. Nakane, T. Kodaka, Y. Suhara, H. Takayama, and K. Waku. 2000. Evidence that 2-arachidonoylglycerol but not N-palmitoylethanolamine or anandamide is the physiological ligand for the cannabinoid CB2 receptor: comparison of the agonistic activities of various cannabinoid receptor ligands in HL-60 cells. J. Biol. Chem. 275: 605-612.
22. Kobayashi, Y., S. Arai, K. Waku, and T. Sugiura. 2001. Activation by 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, of p42/44 mitogen-activated protein kinase in HL-60 cells. J. Biochem. 129: 665-669.
23. Kishimoto, S., Y. Kobayashi, S. Oka, M. Gokoh, K. Waku, and T. Sugiura. 2004. 2-Arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces accelerated production of chemokines in HL-60 cells. J. Biochem. 135: 517-524.
24. Kishimoto, S., M. Gokoh, S. Oka, M. Muramatsu, T. Kajiwara, K. Waku, and T. Sugiura. 2003. 2-Arachidonoylglycerol induces the migration of HL-60 cells differentiated into macrophage-like cells and human peripheral blood monocytes through the cannabinoid CB2 receptor-dependent mechanism. J. Biol. Chem. 278: 24469-24475.
25. Kishimoto, S., M. Muramatsu, M. Gokoh, S. Oka, K. Waku, and T. Sugiura. 2005. Endogenous cannabinoid receptor ligand induces the migration of human natural killer cells. J. Biochem. 137: 217-223.
26. Oka, S., S. Ikeda, S. Kishimoto, M. Gokoh, S. Yanagimoto, K. Waku, and T. Sugiura. 2004. 2-Arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces the migration of EoL-1 human eosinophilic leukemia cells and human peripheral blood eosinophils. J. Leukocyte Biol. 76: 1002-1009.
27. Jorda, M. A., S. E. Verbakel, P. J. Valk, Y. V. Vankan-Berkhoudt, M. Maccarrone, A. Finazzi-Agro, B. Lowenberg, and R. Delwel. 2002. Hematopoietic cells expressing the peripheral cannabinoid receptor migrate in response to the endocannabinoid 2-arachidonoylglycerol. Blood 99: 2786-2793.
28. Walter, L., A. Franklin, A. Witting, C. Wade, Y. Xie, G. Kunos, K. Mackie, and N. Stella. 2003. Nonpsychotropic cannabinoid receptors regulate microglial cell migration. J. Neurosci. 23: 1398-1405.
29. Maestroni, G. J. 2004. The endogenous cannabinoid 2-arachidonoyl glycerol as in vivo chemoattractant for dendritic cells and adjuvant for Th1 response to a soluble protein. FASEB J. 18: 1914-1916.
30. Oka, S., S. Yanagimoto, S. Ikeda, M. Gokoh, S. Kishimoto, K. Waku, Y. Ishima, and T. Sugiura. 2005. Evidence for the involvement of the cannabinoid CB2 receptor and its endogenous ligand 2-arachidonoylglycerol in 12-O-tetradecanoylphorbol-13-acetate-induced acute inflammation in mouse ear. J. Biol. Chem. 280: 18488-18497.
31. Gallily, R., A. Breuer, and R. Mechoulam. 2000. 2-Arachidonylglycerol, an endogenous cannabinoid, inhibits tumor necrosis factor-α production in murine macrophages, and in mice. Eur. J. Pharmacol. 406: R5-R7.
32. Facchinetti, F., E. Del Giudice, S. Furegato, M. Passarotto, and A. Leon. 2003. Cannabinoids ablate release of TNFα in rat microglial cells stimulated with lipopolysaccharide. Glia 41: 161-168.
33. Chang, Y. H., S. T. Lee, and W. W. Lin. 2001. Effects of cannabinoids on LPS-stimulated inflammatory mediator release from macrophages: involvement of eicosanoids. J. Cell. Biochem. 81: 715-723.
34. Ouyang, Y., S. G. Hwang, S. H. Han, and N. E. Kaminski. 1998. Suppression of interleukin-2 by the putative endogenous cannabinoid 2-arachidonyl-glycerol is mediated through down-regulation of the nuclear factor of activated T cells. Mol. Pharmacol. 53: 676-683.
35. Bligh, E. G., and W. J. Dyer. 1959. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37: 911-917.
36. Rouser, G., A. N. Siakotos, and S. Fleischer. 1966. Quantitative analysis of phospholipids by thin-layer chromatography and phosphorus analysis of spots. Lipids 1: 85-86.
37. 2+-dependent and -independent mechanisms. FEBS Lett. 429: 152-156.
38. Sugiura, T., S. Kondo, A. Sukagawa, T. Tonegawa, S. Nakane, A. Yamashita, Y. Ishima, and K. Waku. 1996. Transacylase-mediated and phosphodiesterase- mediated synthesis of N-arachidonoylethanolamine, an endogenous cannabinoid-receptor ligand, in rat brain microsomes: comparison with synthesis from free arachidonic acid and ethanolamine. Eur. J. Biochem. 240: 53-62.
39. Galiegue, S., S. Mary, J. Marchand, D. Dussossoy, D. Carriere, P. Carayon, M. Bouaboula, D. Shire, G. Le Fur, and P. Casellas. 1995. Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur. J. Biochem. 232: 54-61.
40. Lee, M., K. H. Yang, and N. E. Kaminski. 1995. Effects of putative cannabinoid receptor ligands, anandamide and 2-arachidonyl-glycerol, on immune function in B6C3F1 mouse splenocytes. J. Pharmacol. Exp. Ther. 275: 529-536.
41. 2 peripheral cannabinoid receptors during B-cell differentiation. Blood 92: 3605-3615.
42. 2 induces MCP-1 and IL-8 gene expression in human promyelocytic cell line HL60. FEBS Lett. 448: 273-277.
43. Pasparakis, M., L. Alexopoulou, V. Episkopou, and G. Kollias. 1996. Immune and inflammatory responses in TNFa-deficient mice: a critical requirement for TNFα in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response. J. Exp. Med. 184: 1397-1411.
44. Biedermann, T., M. Kneilling, R. Mailhammer, K. Maier, C. A. Sander, G. Kollias, S. L. Kunkel, L. Hultner, and M. Rocken. 2000. Mast cells control neutrophil recruitment during T cell-mediated delayed-type hypersensitivity reactions through tumor necrosis factor and macrophage inflammatory protein 2. J. Exp. Med. 192: 1441-1152.
45. Shibata, M., H. Sueki, H. Suzuki, H. Watanabe, H. Ohtaki, S. Shioda, T. Nakanishi-Ueda, H. Yasuhara, K. Sekikawa, and M. Iijima. 2005. Impaired contact hypersensitivity reaction and reduced production of vascular endothelial growth factor in tumor necrosis factor-α gene-deficient mice. J. Dermatol. 32: 523-533.
46. Chai, O. H., H. K. Lee, Y. C. Lee, M. S. Lee, E. H. Han, H. T. Kim, and C. H. Song. 2005. Roles of TNF-α and IgE in the late phase of contact hypersensitivity induced by trimellitic anhydride. Exp. Mol. Med. 37: 408-417.
47. Lu, B., B. J. Rutledge, L. Gu, J. Fiorillo, N. W. Lukacs, S. L. Kunkel, R. North, C. Gerard, and B. J. Rollins. 1998. Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice. J. Exp. Med. 187: 601-608.
48. Matias, I., P. Pochard, P. Orlando, M. Salzet, J. Pestel, and V. Di Marzo. 2002. Presence and regulation of the endocannabinoid system in human dendritic cells. Eur. J. Biochem. 269: 3771-3778.
49. Iwamura, H., H. Suzuki, Y. Ueda, T. Kaya, and T. Inaba. 2001. In vitro and in vivo pharmacological characterization of JTE-907, a novel selective ligand for cannabinoid CB2 receptor. J. Pharmacol. Exp. Ther. 296: 420-425.
50. 2 receptor inverse agonist, JTE-907, in cutaneous inflammation in mice. Eur. J. Pharmacol. 520: 164-171.
51. Jan, T. R., A. K. Farraj, J. R. Harkema, and N. E. Kaminski. 2003. Attenuation of the ovalbumin-induced allergic airway response by cannabinoid treatment in A/J mice. Toxicol. Appl. Pharmacol. 188: 24-35.
52. Lunn, C. A., J. S. Fine, A. Rojas-Triana, J. V. Jackson, X. Fan, T. T. Kung, W. Gonsiorek, M. A. Schwarz, B. Lavey, J. A. Kozlowski, et al. 2006. A novel cannabinoid peripheral cannabinoid receptor-selective inverse agonist blocks leukocyte recruitment in vivo. J. Pharmacol. Exp. Ther. 316: 780-788.